Cencora (COR) vs Cosmos Health (COSM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cencora (COR) has outperformed Cosmos Health (COSM) over the past year, gaining 2.8% versus a loss of 68.8%. Over five years, COR leads with a +164.7% price change compared with -92.5% for COSM. Cencora is the larger company by market cap ($60.54 billion vs $32.3 million), about 1874.7 times the size.
On valuation, Cosmos Health trades at a lower forward P/E (4.6x vs 16.0x for Cencora). Cencora pays a dividend yielding 0.74%, while Cosmos Health does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COR | COSM |
|---|---|---|
| Share price | $317.25 | $0.3209 |
| Market cap | $60.54B | $32.29M |
| 1-day change | +0.28% | +0.44% |
| YTD return | -6.07% | -35.56% |
| 1-year return | +2.77% | -68.84% |
| 5-year return | +164.68% | -92.47% |
| P/E ratio (TTM) | 23.55 | — |
| Forward P/E | 16.02 | 4.58 |
| EPS (TTM) | $13.47 | $-0.65 |
| Dividend yield | 0.74% | 0.00% |
| Annual dividend | $2.35 | $0.00 |
| Revenue (latest FY) | $321.33B | — |
| Revenue growth (YoY) | +9.31% | — |
| Net income (latest FY) | $1.55B | — |
| Gross margin | 3.57% | — |
| Operating margin | 0.82% | — |
| Net margin | 0.48% | — |
| 52-week high | $377.54 | $1.32 |
| 52-week low | $244.82 | $0.162 |
| Distance from 52-week high | -15.97% | -75.69% |
| Analyst consensus | buy | — |
| Avg. price target upside | +16.39% | — |
| Average volume | 1.34M | 4.24M |
| Shares outstanding | 190.83M | 100.63M |
| Employees | 47,000 | — |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cencora is about 1874.7 times larger than Cosmos Health by market value ($60.54B vs $32.29M).
- COR has outperformed COSM by 71.6 percentage points over the past year.
About Cencora
COR stock →Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally.
Health Care · Other Pharmaceuticals · 47,000 employees
COR vs COSM FAQ
Which is bigger, Cencora or Cosmos Health?
Cencora (COR) is larger, with a market capitalization of $60.54B compared with $32.29M for Cosmos Health (COSM).
Which stock has performed better over the past year, COR or COSM?
COR returned +2.77% over the past 12 months, compared with -68.84% for COSM (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Cencora or Cosmos Health?
Cencora pays a dividend yielding 0.74%, while Cosmos Health does not currently pay a regular dividend.
Are Cencora and Cosmos Health in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.